User: I have a question about the compound with SMILES O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1.
Assistant: Sure, what is your question?
User: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
Assistant: The answer is Phase 1 Clinical Trials
User: I have a question about the {#molecule|chemical|compound!} with {SMILES__description} {SMILES#}.
Assistant: {#Sure, what is your question?|How can I help?|That sounds interesting, how can I help?|Interesting, how can I help?!}
User: {quest#}
Assistant: {#The answer is |!}{answ#}
O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1
O=C(Nc1cnc(-c2ccncc2F)c(-c2cccnc2)n1)C1CC1
N-[5-(3-fluoropyridin-4-yl)-6-pyridin-3-ylpyrazin-2-yl]cyclopropanecarboxamide
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.